ライフサイエンスコーパス: symptomatic

1 3 (43%) never had symptoms and 17 (57%) were symptomatic.

2 infection, visited 3 different schools while symptomatic.

3 ed, unprotected exposure while Patient 1 was symptomatic.

4 The prevalence of symptomatic 50-99% intracranial stenosis increased from

5 mild cognitive impairment (MCI) rather than symptomatic AD patients reveal a remarkable increase of

6 ffect brain connectivity before the onset of symptomatic AD.

7 Symptomatic adults with the Fontan palliation (n = 29) u

8 Children aged 0-17 years, symptomatic adults, and those with an immunocompromising

9 taemia following FCM is common, unrelated to symptomatic adverse events, baseline intestinal or syste

10 in reducing recurrence of any AF by 48% and symptomatic AF by 51% compared with drug therapy over 5

11 non-AIT patients who received at least three symptomatic allergic rhinitis (AR) prescriptions in succ

12 Conclusion: In symptomatic ALS patients, (18)F-DPA714 showed increased

13 ngles and modestly slow cognitive decline in symptomatic Alzheimer's disease (AD).

14 A total of 165 symptomatic and 153 asymptomatic trigeminal nerves were

15 ll subsets were analyzed and correlated with symptomatic and asymptomatic corneal herpesvirus infecti

16 has potential for diagnostic testing of both symptomatic and asymptomatic individuals.

17 using 22,150 urogenital specimens from both symptomatic and asymptomatic men and women collected at

18 genitalium ranged from 96.0% to 99.8% across symptomatic and asymptomatic men and women.

19 t of inflammation within carotid atheroma in symptomatic and asymptomatic patients.

20 ed voluntary Covid-19 testing programmes for symptomatic and asymptomatic staff at a UK teaching hosp

21 is cross-sectional pilot study, we recruited symptomatic and asymptomatic women with C. trachomatis (

22 nitude of splicing changes is similar in pre-symptomatic and late stage tissue.

23 g for COVID-19 and separation of infected or symptomatic and non-infected patients.

24 The majority of studies showed symptomatic and objective improvement of GERD with the d

25 lasma p-tau181 concentration is increased in symptomatic and presymptomatic FAD suggests potential ut

26 Of the 331 patients in this trial, 184 had symptomatic and progressive disease at baseline.

27 However, 8% of female carriers are symptomatic and underrepresented in research due to the

28 For the 65 positive cases, three were pre-symptomatic, and 38 were asymptomatic.

29 highly infectious while asymptomatic or pre-symptomatic, and that an infected person may infect 5.6

30 nifestations, ranging from fetal hydrops and symptomatic anemia requiring lifelong transfusions to fu

31 placement or stabilization would benefit pre-symptomatic ANG-ALS patients.

32 Median (IQR) incidence of symptomatic antibiotic-treated UTIs was 1.0 (0.5-2.5) in

33 Primary outcome was incidence of symptomatic antibiotic-treated UTIs.

34 total of 833 patients across 12 centers with symptomatic aortic stenosis and large aortic annuli unde

35 2032 intermediate-risk patients with severe, symptomatic aortic stenosis at 57 centers.

36 nts comprise antipsychotics which act solely symptomatic, are limited in their effectiveness and ofte

37 In patients with severe symptomatic AS awaiting aortic valve replacement, there

38 ymphangiectasia are characterized by severe, symptomatic ascites refractory to attempts at medical an

39 and GNF179 are effective against Plasmodium symptomatic asexual blood-stage infections, and are able

40 Symptomatic+asymptomatic-monthly had an ICER <$100,000/Q

41 due in part to the challenge of identifying symptomatic, asymptomatic, and pre-symptomatic carriers

42 e likely than matched control subjects to be symptomatic at baseline with a greater symptom severity

43 lation is an increasingly used treatment for symptomatic atrial fibrillation (AF).

44 Symptomatic atrial tachyarrhythmia had recurred in 11.0%

45 rsial, intermittent ADT does seem to provide symptomatic benefit in patients compared with continuous

46 ed 640 scans from 386 subjects, including 54 symptomatic C9orf72 carriers (72.2% behavioral variant F

47 hole blood samples from patients treated for symptomatic CAD including non-ST elevation MI, along wit

48 A/stroke cohorts (n=12 781), all with either symptomatic carotid stenosis or major acute stroke.

49 Participants included symptomatic carriers (n=185) of a pathogenic mutation in

50 We included 106 presymptomatic and 54 symptomatic carriers of a pathogenic mutation in GRN, C9

51 entifying symptomatic, asymptomatic, and pre-symptomatic carriers of the virus.

52 ed information, we estimate that the overall symptomatic case fatality risk (the probability of dying

53 omatic, with similar viral load as that of a symptomatic case.

54 No new symptomatic cases and 300 asymptomatic cases (detection

55 Consequently, even if all symptomatic cases are isolated, a vast outbreak may none

56 With that, when symptomatic cases are not prioritised for testing, a hig

57 ir potential impact, need to look beyond the symptomatic cases if they are to understand and address

58 Viral load of asymptomatic and symptomatic cases is comparable.

59 tudy with intrapatient comparison of 83 very symptomatic cases without significant cardiopathy, submi

60 Rates of symptomatic cases, medical consultations, hospitalizatio

61 relies on prompt detection and treatment of symptomatic cases.

62 acity or when the testing policy prioritises symptomatic cases.

63 e due attention and appropriate treatment in symptomatic cases.

64 ewer cases over the course of infection than symptomatic cases.

65 18 years old with histologically confirmed, symptomatic Castleman disease.

66 Current treatment of AHF is mostly symptomatic, centred on decongestive drugs, at best tail

67 tic children was 10.3 cycles higher than for symptomatic children (P < 0.0001), and VL were 3 to 4 lo

68 001), and VL were 3 to 4 logs lower than for symptomatic children (P < 0.0001); differences were cons

69 112 symptomatic children with presumptive TB were recruited

70 More than 30% of patients with symptomatic cholecystolithiasis reports persisting pain

71 pared with FF/VI or UMEC/VI in patients with symptomatic chronic obstructive pulmonary disease and a

72 Among adults with symptomatic chronic subdural hematoma, most of whom had

73 tients had clinical findings consistent with symptomatic CMV infection.

74 Despite being able to provide symptomatic control, the current biologics do not preven

75 risk of ACM versus UMEC/VI in patients with symptomatic COPD and a history of exacerbations.

76 matic corneas of HSV-1-infected WT mice, the symptomatic corneas CD1d KO mice, with iNKT cell deficie

77 matic corneas of wild-type (WT) B6 mice, the symptomatic corneas of CD1d KO mice, which lack iNKT cel

78 case report describes a pregnant woman with symptomatic coronavirus disease who experienced a second

79 CLL patients diagnosed with symptomatic COVID-19 across 43 international centers (n

80 and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing

81 responses in convalescent serum from mostly symptomatic Covid-19 patients (8344 and 983, respectivel

82 From 10 March to 7 April 2020, 423 cases of symptomatic COVID-19 were diagnosed at Memorial Sloan Ke

83 preliminary study of adult outpatients with symptomatic COVID-19, patients treated with fluvoxamine,

84 800 patients with a diagnosis of cancer and symptomatic COVID-19.

85 ptomatic, and two of them had recovered from symptomatic COVID-19.

86 plasma cryptococcal antigen (CrAg) precedes symptomatic cryptococcal meningitis.

87 t the utility of collecting a diverse set of symptomatic, demographic, exposure and behavioural self-

88 rotypes (DENV) up to Month 36 in part 1, and symptomatic dengue and serious adverse events (SAEs) up

89 While the majority of symptomatic dengue patients experience an acute febrile

90 Risk of symptomatic DENV2 infection and severe disease was eleva

91 secondary mitral regurgitation who remained symptomatic despite maximally tolerated guideline-direct

92 High-risk patients with progressing symptomatic disease currently have only hospitalization

93 uncomplicated diverticular disease (SUDD) to symptomatic disease with complications such as acute div

94 of individuals infected and individuals with symptomatic disease, along with the attributable number

95 viduals but ~25% of individuals will develop symptomatic diverticulosis, termed colonic diverticular

96 n the frontal lobe are potential targets for symptomatic drug treatment of frontotemporal dementia an

97 Patients with symptomatic drug-refractory atrial fibrillation (paroxys

98 e provide evidence that in addition to those symptomatic effects, 4-AP can prevent neuroaxonal loss i

99 f research resulting in treatments with only symptomatic effects.

100 er arises from causal interactions among its symptomatic elements has especially resonated with those

101 etween 12 March 2020 and 23 April 2020, 3477 symptomatic employees were tested for COVID-19 at 2 empl

102 yndrome (POTS), and vasovagal syncope (VVS), symptomatic excessive HR occurs.

103 f ambulatory clinic visits alone for chronic symptomatic FBDs is approximately US$358 million (95% CI

104 The management of chronic symptomatic FBDs is associated with considerable health

105 We aimed to assess the burden of chronic symptomatic FBDs on ambulatory care delivery in the Unit

106 antly reduce reintervention in patients with symptomatic femoropopliteal peripheral artery disease.

107 atients with Parkinson disease, treatment is symptomatic, focused on improvement in motor (eg, tremor

108 oms, the detection of clinical transition to symptomatic FTD may be best captured by composite indice

109 4-h pH-impedance results of 72 patients with symptomatic GOR off anti-secretory therapy was conducted

110 concentration was significantly increased in symptomatic GRN mutation carriers (adjusted mean differe

111 lassified into two distinct groups: the high symptomatic group (Class 1: 57.4%) and the low symptomat

112 mptomatic group (Class 1: 57.4%) and the low symptomatic group (Class 2: 42.6%).

113 cant differences were seen between the other symptomatic groups and controls, or any of the presympto

114 ificantly less MFI in Q1 compared to the two symptomatic groups.

115 gh risk for infection (mainly those who were symptomatic, had recently traveled to high-risk countrie

116 CVD was also marginally associated with symptomatic HAND.

117 that the proportion of both asymptomatic and symptomatic HCWs testing positive for SARS-CoV-2 rapidly

118 Symptomatic head trauma associated with American-style f

119 ul data sensitive to the long-term impact of symptomatic head trauma in former professional ASF playe

120 We hypothesized that ASF-related symptomatic head trauma would predict worse gait perform

121 Failure) trial disclosed DAPA's benefits in symptomatic heart failure, but the underlying mechanism

122 events across a broad range of patients with symptomatic HF and prior HFH.

123 We prospectively analyzed 55 patients with symptomatic HF with impaired left ventricular ejection f

124 parallel-group trial in patients with stable symptomatic HFrEF taking optimal guideline-directed medi

125 rus CUB tended to be more similar to that of symptomatic hosts than that of natural hosts, supporting

126 ally curated list of viruses and natural and symptomatic hosts, we found that virus CUB tended to be

127 sition, and RA signaling was dysregulated in symptomatic human atherosclerosis.

128 Symptomatic hypotension occurred in 9.1% of the patients

129 The proportions of patients who experienced symptomatic hypotension were 6.4% in the 15-mg/d vericig

130 ogressive volumetric deficit associated with symptomatic improvement after clozapine exposure may ref

131 disorder, the role of brain organization for symptomatic improvement remains inadequately defined.

132 cancer when it is asymptomatic (rather than symptomatic) improves survival; thus, imaging surveillan

133 symptom screening and molecular testing for symptomatic individuals by community health-care workers

134 yzed baseline and 2-y follow-up data for 216 symptomatic individuals on the AD continuum (positive am

135 and recommends nucleic acid testing for all symptomatic individuals suspected of having COVID-19.

136 (IQR): 0.73-0.86) for discriminating between symptomatic individuals who were positive or negative fo

137 U/mL as a correlate of protection identified symptomatic individuals with preexposure titers exceedin

138 Of these symptomatic individuals, 54 reported testing positive an

139 Compared with symptomatic individuals, asymptomatic people were less l

140 remained unaffected both in asymptomatic and symptomatic individuals.

141 cidence of PCR-positive test results and new symptomatic infection according to antibody status, adju

142 The risk of symptomatic infection increased with age (for example, a

143 es the likelihood of influenza infection and symptomatic infection we use logistic regression models.

144 rhea, with non-secretors less susceptible to symptomatic infection.

145 This revealed that detection of symptomatic infections decreased throughout February as

146 There were no symptomatic infections in workers with anti-spike antibo

147 aracterized during the initial days of acute symptomatic influenza infection.

148 Children with neurofibromatosis type 1 and symptomatic inoperable plexiform neurofibromas received

149 0.87-0.98), and an increased probability of symptomatic intracerebral hemorrhage (adjusted OR per 30

150 transient ischemic attack/systemic embolism, symptomatic intracerebral hemorrhage (sICH), and major e

151 /TIA/systemic arterial embolism) and delayed symptomatic intracranial haemorrhage (d-sICH) within 90

152 The prevalence of symptomatic intracranial haemorrhage was higher in the a

153 ere disability or death (mRS score 4-6), and symptomatic intracranial haemorrhage.

154 ifference, 2.7% [95% CI, -5.6% to 11.0%]) or symptomatic intracranial hemorrhage (7 [4.7%] vs 2 [1.3%

155 e CTP profiles, EVT was associated with high symptomatic intracranial hemorrhage (sICH) (24%) and mor

156 erity, rates of IVT/mechanical thrombectomy, symptomatic intracranial hemorrhage (sICH), and favorabl

157 oup and 24.5% of those in the control group; symptomatic intracranial hemorrhage occurred in 4.5% of

158 specified time epochs, the elevated risk for symptomatic intracranial hemorrhage was seen only within

159 stantial neurological improvement at 3 days; symptomatic intracranial hemorrhage within 36 hours; and

160 fic prevalence, predictors, and prognosis of symptomatic intracranial stenosis in a population-based

161 ent stroke on intensive medical treatment of symptomatic intracranial stenosis is consistent with the

162 Symptomatic intracranial stenosis was perceived to conve

163 Of 94 patients with 50-99% symptomatic intracranial stenosis, 14 (14.9%) had recurr

164 may explain the clinical disconnect in which symptomatic joint pain patients present without radiogra

165 ve pain and physical function in people with symptomatic knee osteoarthritis, but the benefits of thi

166 Symptomatic KOA progression was defined as an increase i

167 ore profound EMW negativity in patients with symptomatic LQTS compared to those with asymptomatic LQT

168 for months or years, then reactivate causing symptomatic malaria.

169 nfined to application of corticosteroids and symptomatic management, without proven positive effects

170 a substantial number of patients with severe symptomatic mitral regurgitation who are at too high of

171 We generated a symptomatic mouse model of DMD carriers via injection of

172 vandetanib in patients with progressive and symptomatic MTC.

173 myeloma significantly delays progression to symptomatic multiple myeloma and the development of end-

174 xtended release 4-AP is already licensed for symptomatic multiple sclerosis treatment, we performed a

175 Symptomatic mutation carriers had lower NPTX2 concentrat

176 dds on having neurovascular contact over the symptomatic nerves was significantly higher than on the

177 On symptomatic nerves, neurovascular contact with morpholog

178 , dose-ranging phase II study in adults with symptomatic nHCM (New York Heart Association functional

179 or, was well tolerated in most subjects with symptomatic nHCM.

180 first-in-class cardiac myosin inhibitor, in symptomatic obstructive hypertrophic cardiomyopathy.

181 general assessment revealed a renal failure symptomatic of a nephrotic syndrome, associated with pro

182 aturely without appropriate foresight and is symptomatic of a number of neuropsychiatric disorders.

183 an OSDI score of 13 or above were considered symptomatic of DED, and DED was defined if an OSDI score

184 stants and effectively diagnoses mice before symptomatic onset and tracks disease state.

185 ned consecutive patients with cancer who had symptomatic or incidental acute proximal deep-vein throm

186 ma p-tau181 concentration was higher in both symptomatic (p < 0.001) and presymptomatic mutation carr

187 patients who underwent revascularization for symptomatic PAD.

188 ong patients receiving initial treatment for symptomatic, paroxysmal atrial fibrillation, there was a

189 We randomly assigned 303 patients with symptomatic, paroxysmal, untreated atrial fibrillation t

190 participants had faster viral clearance than symptomatic participants (P < .001 for difference over t

191 Only 19.5% (16.3-23.2) of symptomatic participants who were seropositive by both t

192 st help distinguish between asymptomatic and symptomatic participants with carotid stenosis.Materials

193 This is relevant for both prodromal and symptomatic patient populations where potential response

194 EMW outperformed QTc in predicting symptomatic patients (area under the curve: 0.78 vs. 0.7

195 0%, and 75% of the normal monthly volumes of symptomatic patients delayed their presentation until af

196 h excellent tools exist for the diagnosis of symptomatic patients in well-equipped laboratories, impo

197 r, its benefits in asymptomatic or minimally symptomatic patients remain unknown.

198 All symptomatic patients seen in 2017 by an on-call junior r

199 All symptomatic patients suspected of having COVID-19 pneumo

200 mpared matched saliva and NPS specimens from symptomatic patients suspected of having COVID-19.

201 navirus respiratory pathogens in a sample of symptomatic patients undergoing PCR testing in March 202

202 ctive subarachnoid or ventricular disease in symptomatic patients was 100% in CSF and 81.3% in plasma

203 us trials in prion disease have been done in symptomatic patients who are often profoundly debilitate

204 In symptomatic patients with CAD, very low hs-cTn concentra

205 One hundred-twenty consecutive symptomatic patients with COVID-19 infection who had und

206 Sixty-three symptomatic patients with median prior therapies of two

207 ry CTXII may aid in early diagnosis of OA in symptomatic patients without radiographic evidence of OA

208 dings suggest a higher shedding risk in less symptomatic patients, an important consideration for con

209 onal carotid surgery or stenting in selected symptomatic patients, closure of patent foramen ovale af

210 In subgroup analysis among symptomatic patients, the risk of SCD was increased in h

211 SARS-CoV-2 in nasopharyngeal swabs from 108 symptomatic patients.

212 erse remodeling in asymptomatic or minimally symptomatic patients.

213 sed sensitivity using 128 serum samples from symptomatic PCR-confirmed coronavirus disease 2019 (COVI

214 Patients with symptomatic PE and right ventricular to left ventricular

215 (MMSE) and lower brain volume, while in the symptomatic period, higher concentrations were associate

216 Of 2,112 previously symptomatic persons, the proportion seronegative slightl

217 with high bacterial burdens during the acute symptomatic phase of the disease.

218 ics of prophages from 132 ETEC isolates from symptomatic pigs to determine their potential for spread

219 polyomavirus-associated diseases may reduce symptomatic polyomavirus replication while maintaining a

220 d exposure was significantly elevated in the symptomatic population (7.7% vs. 3.6%, p<0.001), especia

221 compare tissue from individuals who are pre-symptomatic (Pre_S) to tissue from patients with late st

222 rolled trial, adults (aged 16-55 years) with symptomatic primary spontaneous pneumothorax were recrui

223 we report that while brain homogenates from symptomatic prion-infected mice are highly toxic to cult

224 gnificantly associated with radiographic and symptomatic progression of KOA.

225 , and existing programmes focus on screening symptomatic rather than asymptomatic staff.

226 are confirmed from those that are suspected, symptomatic recurrence from radiographic recurrence (tha

227 was performed in 159/511 patients (31%) with symptomatic recurrence versus 77/159 (48%) asymptomatic

228 n follow-up of 11 years (range 1 mo-25 yrs), symptomatic recurrence was observed in 61%: 15 patients

229 Freedom from symptomatic recurrent biliary obstruction requiring re-i

230 The primary efficacy outcome, symptomatic recurrent venous thromboembolism (assessed b

231 Symptomatic relatives had a shorter event-free survival

232 veral therapeutic agents have been tried for symptomatic relief, but with varying results.

233 e these underlying processes to provide full symptomatic relief.

234 tely, current ARCI therapies focus solely on symptomatic relief.

235 Black patients were more likely to undergo symptomatic repair and underwent rupture repair at a sma

236 fection-control strategies focused solely on symptomatic residents were not sufficient to prevent tra

237 ion before exposure was highly predictive of symptomatic RSV disease.

238 Symptomatic SARS-CoV-2 infection, termed coronavirus dis

239 s and led to the identification of a low OAB symptomatic score group (cluster 1) and a high OAB sympt

240 matic score group (cluster 1) and a high OAB symptomatic score group (cluster 2).

241 agenomic data based on its representation in symptomatic sea stars compared to asymptomatic sea stars

242 linical hepatitis within the past 12 months (symptomatic seroconversion illness or alanine aminotrans

243 shed in 2019 to assess TAVI in patients with symptomatic severe aortic stenosis at low operative risk

244 In patients with symptomatic severe aortic stenosis, TAVI has now been ex

245 replacement (TAVR) to low-risk patients with symptomatic severe aortic stenosis.

246 er aortic valve replacement in patients with symptomatic severe aortic valve stenosis; and antiplatel

247 eral population, adult patients with PID and symptomatic SID display greater morbidity and mortality

248 ment the outcomes of individuals with PID or symptomatic SID following COVID-19 in the United Kingdom

249 dary end points, including the time to first symptomatic skeletal event and the time to first use of

250 Median time to symptomatic skeletal events was NE (95% CI 20.0-NE) with

251 response, time to pain progression, time to symptomatic skeletal events, and EQ-5D-5L utility index,

252 orkers attending testing of asymptomatic and symptomatic staff at Oxford University Hospitals in the

253 a-amyloid buildup curve plateaus at an early symptomatic stage of Alzheimer disease (AD).

254 ergic nuclei undergo degeneration at the pre-symptomatic stage of Alzheimer's disease (AD).

255 X2 decreased around symptom onset and in the symptomatic stage.

256 kers that capture the risk of decline in pre-symptomatic stages of AD, as this would allow one to foc

257 is, EMW remained an independent predictor of symptomatic status (odds ratio for each 10-ms decrease i

258 Symptomatic status also was associated with the severity

259 rate-corrected QT interval as a predictor of symptomatic status.

260 rom symptomatic stones, clinically diagnosed symptomatic stone episodes from self-reported symptomati

261 om self-reported symptomatic stone episodes, symptomatic stone episodes that are confirmed from those

262 ymptomatic stone episodes from self-reported symptomatic stone episodes, symptomatic stone episodes t

263 For history of symptomatic stones, 49% accept if there is no current ra

264 be aimed at distinguishing asymptomatic from symptomatic stones, clinically diagnosed symptomatic sto

265 Therapeutic options include symptomatic strategies only and are unsatisfactory.

266 The primary outcome was time to death or symptomatic stroke confirmed by imaging, assessed by a n

267 ional therapy for the prevention of death or symptomatic stroke in patients with an unruptured brain

268 ent and interventional therapy in preventing symptomatic stroke or death.

269 , as well as years to/from actual onset in a symptomatic subgroup.

270 ificities, from infected HLA-A*0201 positive symptomatic (SYMP) vs. asymptomatic (ASYMP) individuals

271 c and congenital heart disease patients with symptomatic systolic heart failure and electrical dyssyn

272 Symptomatic teeth were associated with higher levels of

273 ts with ATAs (n = 16) were more likely to be symptomatic than were those without ATAs (n = 28) (P = .

274 et will be an important factor in future pre-symptomatic therapeutic trials for all three genetic gro

275 One symptomatic thrombosis occurred and resolved under aspir

276 mutations, making it possible to obtain pre-symptomatic tissue from eye bank donors to probe how gen

277 vents or reflect the continuous, lower grade symptomatic toxicities that are particularly relevant to

278 anjin, China and estimated the extent of pre-symptomatic transmission by estimating incubation period

279 than incubation periods, suggesting that pre-symptomatic transmission may occur in a large proportion

280 Given the evidence for pre-symptomatic transmission, it is vital that even individu

281 lation (DBS) of the subthalamic nucleus is a symptomatic treatment of Parkinson's disease but benefit

282 s (K(V)1 family) clinically approved for the symptomatic treatment of patients with multiple sclerosi

283 inopyridine (4-AP) is used and licensed as a symptomatic treatment to ameliorate ambulatory disabilit

284 ive framework for both disease-modifying and symptomatic treatment trials in RBD is described, includ

285 matic treatments for RBD, clinical trials of symptomatic treatments are also needed to identify evide

286 erstanding of aetiology, pathophysiology and symptomatic treatments can arise from a transdiagnostic

287 trategies that would expand upon the limited symptomatic treatments currently available for this prog

288 epam and melatonin are most commonly used as symptomatic treatments for RBD, clinical trials of sympt

289 erticular disease can range in severity from symptomatic uncomplicated diverticular disease (SUDD) to

290 Among women with symptomatic uterine fibroids, those who underwent myomec

291 ty evidence that heparin reduces the risk of symptomatic venous thromboembolism for patients with can

292 Clinically diagnosed symptomatic venous thromboembolism occurred in 1.4% of t

293 sm, major adverse cardiovascular events, and symptomatic venous thromboembolism occurred with high fr

294 Symptomatic venous thromboembolism was defined as deep v

295 lity criteria, 529 patients (1.4%) developed symptomatic venous thromboembolism.

296 iver operating curve (AUC) was calculated in symptomatic versus asymptomatic individuals to predict p

297 icacy, as measured by the number of cases of symptomatic, virologically confirmed COVID-19, and safet

298 Two of 9 patients had symptomatic visual loss from the scotoma because it invo

299 tions between aFXa level category and 90-day symptomatic VTE & bleeding.

300 nd warfarin, are used to treat children with symptomatic VTE.